FDA issued a Warning Letter to Signature Formulations, LLC on 7/31/2018 for a previous inspection.
483 Signature Formulations Jun 2019

483 Signature Formulations Jun 2019

$119 - Not in Stock

FDA investigators audited the Signature Formulations - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 19 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Jun 2019
  • Location: Phoenix, United States
  • FEI: 3011368010
Order